Biophytis (France) Executives

ALBPS Stock  EUR 0.06  0  1.89%   
Biophytis employs about 19 people. The company is managed by 10 executives with a total tenure of roughly 35 years, averaging almost 3.0 years of service per executive, having 1.9 employees per reported executive. Discussion of Biophytis' management performance can provide insight into the enterprise performance.
Stanislas Veillet  Chairman
Chairman of the Board, CEO
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biophytis SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Biophytis Management Team Effectiveness

The company has return on total asset (ROA) of (0.6656) % which means that it has lost $0.6656 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (12.444) %, meaning that it generated substantial loss on money invested by shareholders. Biophytis' management efficiency ratios could be used to measure how well Biophytis manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/09/2026, Return On Equity is likely to grow to 1.01, though Return On Tangible Assets are likely to grow to (2.64). As of 02/09/2026, Total Current Liabilities is likely to drop to about 11.1 M. In addition to that, Liabilities And Stockholders Equity is likely to drop to about 7.5 M
As of 02/09/2026, Common Stock Shares Outstanding is likely to grow to about 6.3 M, while Net Loss is likely to drop (9.8 M). Biophytis holds a total of 42.09 Million outstanding shares. Almost 94.58 percent of Biophytis outstanding shares are held by general public with 0.89 (percent) owned by insiders and only 4.52 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2013-06-30
Previous Quarter
6.9 M
Current Value
19.3 M
Avarage Shares Outstanding
M
Quarterly Volatility
17.5 M
 
Yuan Drop
 
Covid
 
Interest Hikes
As of 02/09/2026, Dividend Paid And Capex Coverage Ratio is likely to drop to -0.89. As of 02/09/2026, Common Stock Shares Outstanding is likely to grow to about 6.3 M, while Net Loss is likely to drop (9.8 M).

Biophytis Workforce Comparison

Biophytis SA is rated second in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 119. Biophytis retains roughly 19.0 in number of employees claiming about 16% of equities under Health Care industry.

Biophytis SA Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Biophytis SA Price Series Summation is a cross summation of Biophytis price series and its benchmark/peer.

Biophytis Notable Stakeholders

A Biophytis stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Biophytis often face trade-offs trying to please all of them. Biophytis' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Biophytis' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Stanislas VeilletChairman of the Board, CEOProfile
Waly DiohDirector of Research & DevelopmentProfile
Pierre DildaDirector of ResearchProfile
Rene LafontScientific DirectorProfile
Chiara BaccelliChief DirectorProfile
Edouard BiethChief OfficerProfile
Philippe RousseauChief OfficerProfile
Benoit CanolleChief OfficerProfile
TeylanFinancial ControllerProfile
FFPM MBAChief OfficerProfile
String symbol = request.getParameter("s");

About Biophytis Management Performance

The success or failure of an entity such as Biophytis SA often depends on how effective the management is. Biophytis management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biophytis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biophytis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(2.78)(2.64)
Return On Capital Employed 0.88  0.83 
Return On Assets(1.73)(1.82)
Return On Equity 0.97  1.01 

Biophytis Workforce Analysis

Traditionally, organizations such as Biophytis use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Biophytis within its industry.

Biophytis Manpower Efficiency

Return on Biophytis Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee546.3K
Net Loss Per Executive1M

Additional Tools for Biophytis Stock Analysis

When running Biophytis' price analysis, check to measure Biophytis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biophytis is operating at the current time. Most of Biophytis' value examination focuses on studying past and present price action to predict the probability of Biophytis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biophytis' price. Additionally, you may evaluate how the addition of Biophytis to your portfolios can decrease your overall portfolio volatility.